A

Advanced Pharma CR | Miami, FL

Research site
(Unclaimed)
Location
2950 NW 83rd St, Miami, Florida, United States of America
Site insights

Top conditions

Renal Insufficiency (10 trials)

Diabetes Mellitus (6 trials)

Non-alcoholic Fatty Liver Disease (4 trials)

Ulcer (4 trials)

Type 2 Diabetes Mellitus (4 trials)

Top treatments

INCB050465
S-217622
Ruxolitinib
Bococizumab
ASP0367
Filgotinib
LY3819469
ASP5354
Dapagliflozin
Brazikumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

11 of 67
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function

The goals of this study are to compare the amount of study drug, bulevirtide (BLV), that gets into the bloodstream and how long it takes for the body...

Enrolling
Chronic Hepatitis D Infection
Drug: Bulevirtide (BLV)

The purpose of this study is to evaluate the safety and efficacy of two parsaclisib treatment regimens in participants diagnosed with relapsed or ref...

Active, not recruiting
Lymphoma
Drug: Parsaclisib

The main purpose of this study is to assess the amount of study drug (LY3473329) that reaches the bloodstream and the time it takes for the body to g...

Enrolling
Renal Insufficiency
Drug: LY3473329

The main purpose of this study is to assess the amount of study drug (LY3502970) that reaches the bloodstream and the time it takes for the body to g...

Enrolling
Healthy
Renal Insufficiency
Drug: LY3502970
Locations recently updated

Human immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic di...

Enrolling
Human Immuno-deficiency Virus (HIV) Disease
Drug: Budigalimab
Drug: Placebo for Budigalimab

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: Placebo
Drug: Upadacitinib (ABT-494)

This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Pr...

Enrolling
Prurigo Nodularis
Drug: Ruxolitinib Cream 1.5%

This seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the effi...

Active, not recruiting
Cirrhosis
Prevention of Esophageal Varices
Drug: belapectin
Drug: Placebo

Renal Impairment study of GBT021601.

Enrolling
Renal Impairment
Drug: GBT021601

The goals of this clinical study are to learn more about the study drugs, semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firso...

Active, not recruiting
Nonalcoholic Steatohepatitis
Drug: PTM CILO/FIR
Drug: Cilofexor (CILO)/Firsocostat (FIR)

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Contraception
Drug: MR-100A-01

Trial sponsors

Pfizer logo

Pfizer (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems